Genotoxicity of thallium-201 in patients with angina pectoris undergoing myocardial perfusion study

Tohoku J Exp Med. 2005 Aug;206(4):299-304. doi: 10.1620/tjem.206.299.

Abstract

Thallium-201 (201Tl) has been widely used as a nuclear reagent for myocardial blood flow imaging. The purpose of this study was to investigate genotoxic effects of 201Tl in patients with angina pectoris (n = 21), who had undergone myocardial perfusion imaging. Lymphocytes were isolated from each patient before, and 3, 30 and 90 days after 201Tl administration (111 MBq, 3 mCi) and were analyzed for chromosomal aberrations, sister chromatid exchanges, mitotic index and replicative index. There were significant increases in chromosomal aberrations and sister chromatid exchanges 3 days after 201Tl administration (p < 0.001), although no difference was noted in these values after 30 and 90 days (p > 0.05). Moreover, decreased mitotic index and replicative index were noted after 3 days of 201Tl administration (p < 0.001). These results suggest that the administration of 201Tl for myocardial blood flow imaging may induce genetic damage.

MeSH terms

  • Angina Pectoris / diagnosis*
  • Chromosome Aberrations
  • Coronary Circulation*
  • DNA / radiation effects*
  • DNA Damage
  • Diagnostic Imaging
  • Female
  • Humans
  • Lymphocytes / drug effects
  • Lymphocytes / physiology
  • Male
  • Middle Aged
  • Mutagenicity Tests
  • Regional Blood Flow
  • Sister Chromatid Exchange
  • Thallium Radioisotopes / adverse effects*
  • Time Factors

Substances

  • Thallium Radioisotopes
  • DNA